Other Species / Isoforms
  PARVA (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T3-p
_____MAtsPQKsPs
Upstream
0 5
Treatment
  • vemurafenib
PARVA (human) _____MAtsPQKsPs T3-p
PARVA iso2 (human) _____MATSPQKSPS T3
PARVA (mouse) _____MAtsPQKsPL T3-p
PARVA (rat) _____MATSPQKsPS T3
S4-p
____MAtsPQKsPsV
Upstream
Downstream
2 6
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell adhesion, induced
  • cell motility, induced
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • nocodazole
  • U0126
PARVA (human) ____MAtsPQKsPsV S4-p
PARVA iso2 (human) ____MATSPQKSPSV S4
PARVA (mouse) ____MAtsPQKsPLV S4-p
PARVA (rat) ____MATSPQKsPSV S4
S8-p
MAtsPQKsPsVPKsP
Upstream
Downstream
3 31
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell adhesion, induced
  • cell motility, induced
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • EGF
  • MG132_withdrawal
  • selumetinib
  • U0126
  • vemurafenib
PARVA (human) MAtsPQKsPsVPKsP S8-p
PARVA iso2 (human) MATSPQKSPSVPKSP S8
PARVA (mouse) MAtsPQKsPLVPKsP S8-p
PARVA (rat) MATSPQKsPSVPKsP S8-p
S10-p
tsPQKsPsVPKsPtP
0 6
PARVA (human) tsPQKsPsVPKsPtP S10-p
PARVA iso2 (human) TSPQKSPSVPKSPTP S10
PARVA (mouse) tsPQKsPLVPKsPtP L10
PARVA (rat) TSPQKsPSVPKsPtP S10
S14-p
KsPsVPKsPtPKsPP
Upstream
1 61
Treatment
  • BI2536
  • ischemia
  • selumetinib
  • vemurafenib
PARVA (human) KsPsVPKsPtPKsPP S14-p
PARVA iso2 (human) KSPSVPKSPTPKSPP S14
PARVA (mouse) KsPLVPKsPtPKsPP S14-p
PARVA (rat) KsPSVPKsPtPKsPP S14-p
T16-p
PsVPKsPtPKsPPsR
Upstream
1 25
Treatment
  • selumetinib
  • vemurafenib
PARVA (human) PsVPKsPtPKsPPsR T16-p
PARVA iso2 (human) PSVPKSPTPKSPPSR T16
PARVA (mouse) PLVPKsPtPKsPPsR T16-p
PARVA (rat) PSVPKsPtPKsPPSR T16-p
S19-p
PKsPtPKsPPsRKKD
Upstream
1 69
Treatment
  • BI2536
  • EGF
  • ischemia
PARVA (human) PKsPtPKsPPsRKKD S19-p
PARVA iso2 (human) PKSPTPKSPPSRKKD S19
PARVA (mouse) PKsPtPKsPPsRKKD S19-p
PARVA (rat) PKsPtPKsPPSRKKD S19-p
S22-p
PtPKsPPsRKKDDsF
0 3
PARVA (human) PtPKsPPsRKKDDsF S22-p
PARVA iso2 (human) PTPKSPPSRKKDDSF S22
PARVA (mouse) PtPKsPPsRKKDDsF S22-p
PARVA (rat) PtPKsPPSRKKDDsF S22
S28-p
PsRKKDDsFLGkLGG
Upstream
0 16
Treatment
  • BI_4834
  • MG132_withdrawal
PARVA (human) PsRKKDDsFLGkLGG S28-p
PARVA iso2 (human) PSRKKDDSFLGKLGG S28
PARVA (mouse) PsRKKDDsFLGkLGG S28-p
PARVA (rat) PSRKKDDsFLGkLGG S28-p
K32-ac
KDDsFLGkLGGtLAR
0 5
PARVA (human) KDDsFLGkLGGtLAR K32-ac
PARVA iso2 (human) KDDSFLGKLGGTLAR K32
PARVA (mouse) KDDsFLGkLGGtLAR K32-ac
PARVA (rat) KDDsFLGkLGGTLAR K32-ac
K32-ub
KDDsFLGkLGGtLAR
0 1
PARVA (human) KDDsFLGkLGGtLAR K32-ub
PARVA iso2 (human) KDDSFLGKLGGTLAR K32
PARVA (mouse) KDDsFLGKLGGtLAR K32
PARVA (rat) KDDsFLGKLGGTLAR K32
T36-p
FLGkLGGtLARRKKA
0 14
PARVA (human) FLGkLGGtLARRKKA T36-p
PARVA iso2 (human) FLGKLGGTLARRKKA T36
PARVA (mouse) FLGkLGGtLARRKKA T36-p
PARVA (rat) FLGkLGGTLARRKKA T36
N58
EEGMNAINLPLsPIP
0 1
PARVA (human) EEGMNAINLPLsPIP N58
PARVA iso2 (human) EEGMNAINLPLSPIP N58
PARVA (mouse) EEGMNAInLPLSPIS N58-ng
PARVA (rat) EEGMNAINLPLSPIS N58
S62-p
NAINLPLsPIPFELD
0 5
PARVA (human) NAINLPLsPIPFELD S62-p
PARVA iso2 (human) NAINLPLSPIPFELD S62
PARVA (mouse) NAInLPLSPISFELD S62
PARVA (rat) NAINLPLSPISFELD S62
T82-p
LEENEVRtMVDPNSR
0 2
PARVA (human) LEENEVRtMVDPNSR T82-p
PARVA iso2 (human) LEENEVRTMVDPNSR T82
PARVA (mouse) LEENEVRTMVDPNsR T82
PARVA (rat) LEENEVRTMVDPNSR T82
S88
RtMVDPNSRSDPkLQ
0 1
PARVA (human) RtMVDPNSRSDPkLQ S88
PARVA iso2 (human) RTMVDPNSRSDPKLQ S88
PARVA (mouse) RTMVDPNsRNDPKLQ S88-p
PARVA (rat) RTMVDPNSRNDPkLQ S88
K93
PNSRSDPKLQELMKV
0 1
PARVA (human) PNSRSDPKLQELMKV K93
PARVA iso2 (human) PNSRSDPKLQELMKV K93
PARVA (mouse) PNsRNDPKLQELMKV K93
PARVA (rat) PNSRNDPkLQELMKV K93-ac
K93-ub
PNSRSDPkLQELMKV
0 1
PARVA (human) PNSRSDPkLQELMKV K93-ub
PARVA iso2 (human) PNSRSDPKLQELMKV K93
PARVA (mouse) PNsRNDPKLQELMKV K93
PARVA (rat) PNSRNDPKLQELMKV K93
K117
VGERIIVKDLAEDLy
0 1
PARVA (human) VGERIIVKDLAEDLy K117
PARVA iso2 (human) VGERIIVKDLAEDLY K117
PARVA (mouse) VGERIIVKDLAEDLY K117
PARVA (rat) VGERIIVkDLAEDLY K117-ac
Y124-p
KDLAEDLyDGQVLQk
0 10
PARVA (human) KDLAEDLyDGQVLQk Y124-p
PARVA iso2 (human) KDLAEDLYDGQVLQK Y124
PARVA (mouse) KDLAEDLYDGQVLQK Y124
PARVA (rat) kDLAEDLYDGQVLQK Y124
K131-ub
yDGQVLQkLFEkLES
0 1
PARVA (human) yDGQVLQkLFEkLES K131-ub
PARVA iso2 (human) YDGQVLQKLFGRRVE K131
PARVA (mouse) YDGQVLQKLFEKLES K131
PARVA (rat) YDGQVLQKLFEkLES K131
K135
VLQkLFEKLESEkLN
0 1
PARVA (human) VLQkLFEKLESEkLN K135
PARVA iso2 (human) VLQKLFGRRVECCNG R135
PARVA (mouse) VLQKLFEKLESEkLN K135
PARVA (rat) VLQKLFEkLESEkLN K135-ac
K135-ub
VLQkLFEkLESEkLN
0 1
PARVA (human) VLQkLFEkLESEkLN K135-ub
PARVA iso2 (human) under review -
PARVA (mouse) VLQKLFEKLESEkLN K135
PARVA (rat) VLQKLFEKLESEkLN K135
K140
FEkLESEKLNVAEVT
0 1
PARVA (human) FEkLESEKLNVAEVT K140
PARVA iso2 (human) gap -
PARVA (mouse) FEKLESEKLNVAEVT K140
PARVA (rat) FEkLESEkLNVAEVT K140-ac
K140-ub
FEkLESEkLNVAEVT
0 2
PARVA (human) FEkLESEkLNVAEVT K140-ub
PARVA iso2 (human) gap -
PARVA (mouse) FEKLESEkLNVAEVT K140-ub
PARVA (rat) FEkLESEKLNVAEVT K140
K154-ub
TQSEIAQkQkLQTVL
0 1
PARVA (human) TQSEIAQkQkLQTVL K154-ub
PARVA iso2 (human) under review -
PARVA (mouse) TQSEIAQKQKLQTVL K154
PARVA (rat) TQSEIAQKQKLQTVL K154
K156-ub
SEIAQkQkLQTVLEK
0 1
PARVA (human) SEIAQkQkLQTVLEK K156-ub
PARVA iso2 (human) under review -
PARVA (mouse) SEIAQKQKLQTVLEK K156
PARVA (rat) SEIAQKQKLQTVLEK K156
T167-p
VLEKINEtLKLPPRs
0 1
PARVA (human) VLEKINEtLKLPPRs T167-p
PARVA iso2 (human) gap -
PARVA (mouse) VLEKINETLkLPPRS T167
PARVA (rat) VLEKINEALKLPPRS A167
K169
EKINEtLKLPPRsIK
0 1
PARVA (human) EKINEtLKLPPRsIK K169
PARVA iso2 (human) gap -
PARVA (mouse) EKINETLkLPPRSIK K169-ub
PARVA (rat) EKINEALKLPPRSIK K169
S174-p
tLKLPPRsIKWNVDS
0 6
PARVA (human) tLKLPPRsIKWNVDS S174-p
PARVA iso2 (human) gap -
PARVA (mouse) TLkLPPRSIKWNVDS S174
PARVA (rat) ALKLPPRSIKWNVDS S174
T252-p
HERDAFDtLFDHAPD
0 3
PARVA (human) HERDAFDtLFDHAPD T252-p
PARVA iso2 (human) gap -
PARVA (mouse) HERDAFDTLFDHAPD T252
PARVA (rat) HERDAFDtLFDHAPD T252-p
K260
LFDHAPDKLNVVKkT
0 1
PARVA (human) LFDHAPDKLNVVKkT K260
PARVA iso2 (human) gap -
PARVA (mouse) LFDHAPDKLNVVKkT K260
PARVA (rat) LFDHAPDkLNVVKKT K260-ac
K260-ub
LFDHAPDkLNVVKkT
0 2
PARVA (human) LFDHAPDkLNVVKkT K260-ub
PARVA iso2 (human) gap -
PARVA (mouse) LFDHAPDKLNVVKkT K260
PARVA (rat) LFDHAPDKLNVVKKT K260
K266-m1
DkLNVVKkTLITFVN
0 1
PARVA (human) DkLNVVKkTLITFVN K266-m1
PARVA iso2 (human) gap -
PARVA (mouse) DKLNVVKKTLITFVN K266
PARVA (rat) DkLNVVKKTLITFVN K266
K266
DkLNVVKKTLITFVN
0 1
PARVA (human) DkLNVVKKTLITFVN K266
PARVA iso2 (human) gap -
PARVA (mouse) DKLNVVKkTLITFVN K266-ub
PARVA (rat) DkLNVVKKTLITFVN K266
K274
TLITFVNKHLNKLNL
0 1
PARVA (human) TLITFVNKHLNKLNL K274
PARVA iso2 (human) gap -
PARVA (mouse) TLITFVNKHLNKLNL K274
PARVA (rat) TLITFVNkHLNKLNL K274-ac
T284-p
NKLNLEVtELETQFA
0 1
PARVA (human) NKLNLEVtELETQFA T284-p
PARVA iso2 (human) gap -
PARVA (mouse) NKLNLEVTELETQFA T284
PARVA (rat) NKLNLEVTELETQFA T284
K343-ub
DGGLEKPkPRPEDIV
0 1
PARVA (human) DGGLEKPkPRPEDIV K343-ub
PARVA iso2 (human) under review -
PARVA (mouse) DGGLEKPKPRPEDIV K343
PARVA (rat) DGGLEKPKPRPEDIV K343